Room: Track 4
Theranostics as a new field of medicine combines radiation therapy and nuclear medicine imaging together to provide a transition from conventional medicine to personalized precision medicine. This symposium aims to introduce the basics of theranostics and describe its emerging agents, status and opportunities, training needed, physics in radiation safety and dosimetry, as well as clinical applications. Physicists, physicians and technologists who may not have the knowledge but wish to better understand theranostics and utilize the resources in setting up theranostic agents for clinical patients are expected to attend the symposium.
Introduction to Theranostics (Michael Graham, PhD, MD)
This lecture will describe the basics, the principle and the status of theranostics, focusing on 68Ga and ¹8F based emerging theranostic agents and their development, as well as the current status, challenges and opportunities of theranostics in imaging and therapy.
Physics in Theranostics (George Sgouros, PhD)
This lecture will describe the physics of theranostics, focusing on radiation safety of theranostic agents, dosimetry calculations from 68Ga-Dotatate and 68Ga-PSMA PET, as well as the roles of technologists and physicists together with the training needed for theranostics practice.
Clinical Applications of Theranostics (Mona Natwa, MD)
This lecture will describe clinical applications of theranostics, focusing on paired imaging-therapy applications (68Ga-Dotatate PET and ¹77Lu-Dotatate treatment, 68Ga-PSMA PET and ¹77Lu-PSMA treatment, etc.), as well as the role of NM physicians and the training needed for theranostics practice.
1. Learn and understand the basics of theranostics.
2. Understand and describe the roles of technologists/physicists/physicians as well as training needed for theranostics practice
3. Learn the physics involved in theranostics and explore new initiatives in its clinical applications.